Navigation Links
Pharmaceutical Insiders with Proof of Company’s Improper Relationships: Federal Law Offers Whistleblowers Opportunity for Sizable Financial Compensation, Parker Waichman LLP Says
Date:10/22/2013

New York, New York (PRWEB) October 22, 2013

Parker Waichman LLP, a national law firm that represents whistleblowers in qui tam cases, is looking to inform potential whistleblowers in the pharmaceutical industry that if they have proof of an improper relationship between their firm and a government entity, such as a regulating agency, financial opportunities abound, courtesy of the federal government.

One recent example involving a potential unlawful relationship between a regulator and one or more pharmaceutical companies centers on a scientific panel charged with shaping the federal government’s policy for testing the safety and effectiveness of painkillers. As The Washington Post reported on Oct. 6, 2013, major pharmaceutical companies funded the panel, paying hundreds of thousands of dollars for an opportunity “to affect the thinking” of the U.S. Food and Drug Administration (FDA), according to hundreds of emails that were obtained via a public records request.

The emails show, The Washington Post noted, that the pharmaceutical companies paid as much as $25,000 to attend panel meetings. Two medical professors, Robert Dworkin of the University of Rochester and Dennis Turk of the University of Washington, organized the panel, and as The Washington Post reported, the emails mainly described their efforts at financing and organizing the group and its meetings.

The Post article further noted that the FDA has been disparaged for failing to put in place stricter precautions that might have helped the U.S. to avoid the, “epidemic of addiction to prescription drugs,” such as Oxycontin and other opioids.

Sen. Joe Manchin III has since called for an investigation into “pay to play” allegations regarding the scientific panel, The Washing Post reported on Oct. 9, 2013. In a letter to FDA Commissioner Margaret Hamburg, noted in the Oct. 9 Washington Post report, Manchin requested a list of documents be turned over to his office; the list included the names of all the companies that had paid to attend the panel’s meetings, as well as how much they paid. Also of interest, the Post article added, were any emails between the companies’ event organizers and FDA officials.

The Oct. 9 Washing Post report added that Manchin (D-W. Va.) had been pushing the FDA to place stricter limits on hydrocodone — a key ingredient in the painkillers Vicodin and Lortab — due to its, “addictive power and widespread availability.” Pharmacy companies and others have disagreed with this tact, the Post report noted, claiming that additional restrictions, “could unfairly put the drugs out of reach for patients who need them.”

In recent years many pharmaceutical employees have come forward to report fraudulent billing, illegal marketing techniques and undisclosed drug side effects. These people – known as whistleblowers – have helped the federal government recover billions of dollars obtained illegally by pharmaceutical companies. Whistleblowers have also helped save the lives of countless prescription drug and medical device users who were previously unaware of the side effects of their device or prescription.

Specifically, the Civil War-era False Claims Act provides whistleblowers with protection and the opportunity for compensation. Amendments added to the Act in 1986 helped to incentivize whistleblowers to come forward, primarily by raising the amounts that can be charged for damages and penalties; whistleblowers can be awarded millions of dollars today; between 15% and 30% of the amount recovered by the government.

Anyone who possesses proof that a pharmaceutical company has engaged in an unlawful relationship and is thereby committing fraudulent activity against the federal government is encouraged to contact us. Please view our Qui Tam page or call 1-800-LAW-INFO (1-800-529-4636).

Contact:
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
1+(800) LAW-INFO
1+(800) 529-4636
http://www.yourlawyer.com

Read the full story at http://www.prweb.com/releases/whistleblower_FDA_panel/painkillers/prweb11256696.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Global, common approach to pharmaceutical supply chain integrity the focus of workshop
2. MSU invention could help pharmaceutical industry save money
3. Nobel laureate to keynote international pharmaceutical conference at URI
4. 5 more pharmaceutical companies join NIH initiative to speed therapeutic discovery
5. Is it constitutional for states to regulate pharmaceutical gifts and meals to doctors?
6. Pharmica Consulting to Hold HIT Conference for the Pharmaceutical Industry
7. Scientists use sound waves to levitate liquids, improve pharmaceuticals
8. Medical care presents update on pharmaceutical health services research
9. Taiho Pharmaceutical unveils data on 8 novel anticancer compounds
10. Environmentally friendly chemistry important for manufacturing pharmaceuticals
11. Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... On June ... sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, ... of the city’s history as home to some of the world’s leading providers of ...
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
(Date:6/24/2016)... 24, 2016   Bay Area Lyme Foundation ... Dean Center for Tick Borne Illness , Harvard ... MIT Hacking Medicine, University of California, Berkeley, and ... the five finalists of Lyme Innovation , ... than 100 scientists, clinicians, researchers, entrepreneurs, and investors ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June 24, 2016 ... mobile pulmonary function testing company, is now able to perform sophisticated ... by ndd Medical Technologies , Inc. Patients ... hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients ... get any needed testing done in the comfort of her own ...
Breaking Medicine Technology: